Leerink Pharmaceutical Fund LP — Form D/A
Leerink Pharmaceutical Fund LP of BOSTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2017-12-06. The offering totals $83.5M, of which $83.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-12-06
- Form: D/A
- Accession: 0001610059-17-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $83.5M
- Amount sold: $83.5M
- Investors: 11
- Date of first sale: 2014-07-01
- Security types: fund interests
- SEC file number: 021-219920
Issuer
- Name: Leerink Pharmaceutical Fund LP
- CIK: 0001610059
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: ONE FEDERAL STREET, BOSTON, MA, 02110
- Phone: 617-918-4514
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| GP LP Leerink Pharmaceutical Fund | Executive Officer | Boston, MA |
Other filings by this issuer (4)
More